Is Gilead Sciences Stock a Buy After 2 Recent Wins?
Gilead Sciences (NASDAQ: GILD) hasn't generated excitement among investors in quite a while. However, the big biotech reported two new developments recently that at least hold the potential to boost its fortunes. In this Motley Fool Live video, recorded on March 10, Fool.com contributors Keith Speights and Brian Orelli discuss whether or not Gilead stock is a buy after its two wins.
Source Fool.com